Aliya F Rehman, Alex F Lazo-Vasquez, Parjanya K Bhatt, Tanya Quiroz, Joelle-Ann Joseph, Sibel Gultekin, Nadine Montreuil, Candice A Sternberg, Folusakin Ayoade
KEY CLINICAL MESSAGE: In patients with appropriate epidemiological risk factors, neurocysticecosis should be considered as part of the differential diagnosis of suprasellar or parasellar mass lesions. As neuroimaging findings can be nonspecific, serology may be helpful, but when still in doubt, brain biopsy, and histopathology may be necessary to make the correct diagnosis. ABSTRACT: Neurocysticercosis (NCC) is a well-documented central nervous system helminth infection that is, frequently observed in developing countries...
December 2023: Clinical Case Reports